House Bill No. 350 aims to enhance the management and administration of glucagon medication in public and private school settings in Texas. The bill introduces new definitions for "glucagon medication" and clarifies the terms "school" and "school employee" to include open-enrollment charter schools. It mandates that school districts, open-enrollment charter schools, and private schools may adopt policies for the maintenance, administration, and disposal of glucagon medication. The policies must allow school nurses or unlicensed diabetes care assistants to administer glucagon to students experiencing hypoglycemia, provided that a diabetes management plan and an individualized health plan are in place. Additionally, the bill ensures that schools are not required to incur costs related to the purchase or maintenance of glucagon medication that would negatively impact their finances.

Furthermore, the bill allows physicians to prescribe glucagon medication in the name of schools and provides guidelines for the administration of the medication without requiring a patient-specific standing order. It also stipulates that a pharmacist can dispense glucagon medication to schools without needing identifying information about the user. The provisions of this act will take effect starting with the 2025-2026 school year, and it will become effective immediately if it receives a two-thirds vote from both houses of the legislature; otherwise, it will take effect on September 1, 2025.

Statutes affected:
Introduced: Health and Safety Code 168.001 (Health and Safety Code 168)